SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 340.86 |
| Enterprise Value ($M) | 86.78 |
| Book Value ($M) | 252.45 |
| Book Value / Share | 4.46 |
| Price / Book | 1.35 |
| NCAV ($M) | 248.07 |
| NCAV / Share | 4.38 |
| Price / NCAV | 1.37 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.19 |
| Return on Assets (ROA) | -0.16 |
| Return on Equity (ROE) | -0.17 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 34.61 |
| Current Ratio | 34.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 257.24 |
| Assets | 261.63 |
| Liabilities | 9.18 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13D/A | Logos Global Management LP | 7.50 | 50.49 | |
| 13G/A | Cormorant Asset Management, LP | 0.00 | -100.00 | |
| 13G/A | Citadel Advisors Llc | 3.30 | ||
| 13G/A | State Street Corp | 1.24 | -77.11 | |
| 13G/A | Ra Capital Management, L.p. | 0.00 | -100.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 37,728 | 224,372 | 16.81 | |
| 71,991 | 287,578 | 25.03 | |
| 139,932 | 375,306 | 37.28 | |
| 32,946 | 171,852 | 19.17 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CYTK – Cytokinetics, Incorporated | DAWN – Day One Biopharmaceuticals, Inc. |
| DNLI – Denali Therapeutics Inc. | DVAX – Dynavax Technologies Corporation |
| EDIT – Editas Medicine, Inc. |
Financial data and stock pages provided by
Fintel.io